^ false
^ false
Historical GERN stock prices (quote) - Geron Corporation ^ false Find the historical stock prices of Geron Corporation (GERN)"> ^ false Find the historical stock prices of Geron Corporation (GERN)"/>
GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:GERN
^ false

Geron Corporation Stock Price (Quote)

$3.73
+0.0400 (+1.08%)
At Close: Apr 22, 2024

Range Low Price High Price Comment
30 days $3.05 $4.05 Monday, 22nd Apr 2024 GERN stock ended at $3.73. This is 1.08% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 5.26% from a day low at $3.61 to a day high of $3.80.
90 days $1.64 $4.05
52 weeks $1.64 $4.05

Historical Geron Corporation prices

Date Open High Low Close Volume
Sep 15, 2023 $2.30 $2.32 $2.18 $2.21 15 926 081
Sep 14, 2023 $2.25 $2.34 $2.22 $2.30 4 742 341
Sep 13, 2023 $2.34 $2.41 $2.24 $2.25 11 136 385
Sep 12, 2023 $2.59 $2.66 $2.25 $2.30 18 470 929
Sep 11, 2023 $2.45 $2.48 $2.28 $2.34 4 688 141
Sep 08, 2023 $2.47 $2.50 $2.42 $2.45 4 047 315
Sep 07, 2023 $2.45 $2.50 $2.42 $2.45 4 384 853
Sep 06, 2023 $2.44 $2.47 $2.40 $2.45 2 729 626
Sep 05, 2023 $2.45 $2.54 $2.43 $2.44 4 534 468
Sep 01, 2023 $2.47 $2.54 $2.43 $2.48 7 385 695
Aug 31, 2023 $2.38 $2.45 $2.34 $2.43 6 213 093
Aug 30, 2023 $2.32 $2.38 $2.27 $2.38 7 281 983
Aug 29, 2023 $2.30 $2.40 $2.22 $2.30 8 990 665
Aug 28, 2023 $2.47 $2.52 $2.42 $2.44 3 062 335
Aug 25, 2023 $2.33 $2.53 $2.32 $2.47 6 442 681
Aug 24, 2023 $2.28 $2.35 $2.26 $2.31 4 523 438
Aug 23, 2023 $2.28 $2.39 $2.26 $2.29 5 701 428
Aug 22, 2023 $2.57 $2.57 $2.21 $2.28 12 747 253
Aug 21, 2023 $2.68 $2.68 $2.38 $2.63 9 884 992
Aug 18, 2023 $2.54 $2.70 $2.53 $2.61 7 764 193
Aug 17, 2023 $2.72 $2.74 $2.54 $2.55 5 880 347
Aug 16, 2023 $3.00 $3.00 $2.70 $2.70 6 868 088
Aug 15, 2023 $2.89 $3.02 $2.89 $2.98 2 729 573
Aug 14, 2023 $3.03 $3.01 $2.87 $2.91 3 429 966
Aug 11, 2023 $3.01 $3.07 $2.99 $3.02 3 164 487
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

^ false

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT